BASILIXIMAB

UNII:	9927MT646M
Formula:
Preferred Substance Name:	BASILIXIMAB

179045-86-4
BASILIXIMAB [EMA EPAR]
BASILIXIMAB [INN]
BASILIXIMAB [JAN]
BASILIXIMAB [MART.]
BASILIXIMAB [MI]
BASILIXIMAB [PURPLE BOOK CDER]
BASILIXIMAB [USAN]
BASILIXIMAB [VANDF]
BASILIXIMAB [WHO-DD]
CHI-621
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL CHI621 HEAVY CHAIN ANTIHUMAN INTERLEUKIN 2 RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL CHI621 HEAVY CHAIN ANTIHUMAN INTERLEUKIN 2 RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR) (HUMAN-MOUSE MONOCLONAL CHI621 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR) (HUMAN-MOUSE MONOCLONAL CHI621 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL CHI621 LIGHT CHAIN, DIMER
SDZCHI621
SDZ-CHI-621
SIMULECT

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BASILIXIMAB

Synonyms and Mappings

Resources